MedTrace Logo

Prenatal DHA and Neurofunctional Development

NCT02709239 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-10-19

No results posted yet for this study

Summary

The purpose of this study is to learn how much DHA to give to mothers in order to provide enough to the baby. Researchers will also learn if there are differences in development of the baby up to 12 months after birth.

Conditions

  • Use and Dose of Prenatal DHA Supplementation

Interventions

DIETARY_SUPPLEMENT

DHA 200mg

4 50mg capsules of DHA to be taken by mouth daily

DIETARY_SUPPLEMENT

DHA 800mg

4 200mg capsules of DHA to be taken by mouth daily

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Kathleen Gustafson, PhD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2020-08-20
Completion
2021-08-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02709239 on ClinicalTrials.gov